Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

PetMed Express, Inc. PETS NASDAQ

NASDAQ Global Select • Healthcare • Medical - Pharmaceuticals • US • USD

SharesGrow Score
49/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$11.00
+368.1%

PetMed Express, Inc. (PETS) is a Medical - Pharmaceuticals company in the Healthcare sector, currently trading at $2.35. It has a SharesGrow Score of 49/100, indicating a mixed investment profile with 2 out of 7 criteria passed.

Analyst consensus target is PETS = $11 (+368.1% upside).

Valuation: PETS trades at a trailing Price-to-Earnings (P/E) of -0.7 (S&P 500 average ~25).

Financials: revenue is $227M, -5.3%/yr average growth. Net income is $6M (loss), growing at -1128.7%/yr. Net profit margin is -2.8% (negative). Gross margin is 30.5% (+1.9 pp trend).

Balance sheet: total debt is $996,000 against $85M equity (Debt-to-Equity (D/E) ratio 0.01, conservative). Current ratio is 1.26 (adequate). Debt-to-assets is 0.7%. Total assets: $149M.

Analyst outlook: 2 / 10 analysts rate PETS as buy (20%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 15/100 (Fail), Past 50/100 (Partial), Health 75/100 (Pass), Moat 40/100 (Fail), Future 52/100 (Partial), Income 10/100 (Fail).

$11.00
▲ 368.09% Upside
Average Price Target
Based on 10 Wall Street analysts offering 12-month price targets for PetMed Express, Inc., the average price target is $11.00, with a high forecast of $19.00, and a low forecast of $7.00.
Highest Price Target
$19.00
Average Price Target
$11.00
Lowest Price Target
$7.00

PETS SharesGrow Score Overview

49/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 100/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 50/100
strong — trend
HEALTH 75/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 40/100
Gross margin is + market cap
FUTURE 52/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — PETS

✓
VALUE Pass
100/100
PETS trades at a trailing Price-to-Earnings (P/E) of -0.7 (S&P 500 average ~25). Forward PEG -0.01 — Peter Lynch undervalued (≤1.0). Trailing PEG 0.04. Analyst consensus target is $11, implying +368.1% from the current price $2. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
✗
GROWTH Fail
15/100
PETS: -5.3%/yr revenue is, -1128.7%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
~
PAST Partial
50/100
PETS: 2 / 4 years profitable. weak. Score = 2 / 4 × 100. ≥ 80 = Pass.
View details →
✓
HEALTH Pass
75/100
Balance sheet PETS: Debt-to-Equity (D/E) ratio 0.01 (conservative), Current ratio is 1.26 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
40/100
PETS: Gross margin is 30.5% (+1.9 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 40/100. ≥ 70 = Pass.
View details →
~
FUTURE Partial
52/100
Analyst outlook: 2 / 10 analysts rate PETS as buy (20%). Analyst consensus target is $11 (+368.1% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
10/100
PETS: Net profit margin is -2.8%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range1.57-4.32
Volume47.92K
Avg Volume (30D)118.31K
Market Cap$50.29M
Beta (1Y)0.78
Share Statistics
EPS (TTM)-0.30
Shares Outstanding$20.6M
IPO Date1999-04-26
Employees287
CEOLeslie C. G. Campbell
Financial Highlights & Ratios
Revenue (TTM)$226.97M
Gross Profit$69.14M
EBITDA$6.71M
Net Income$-6.27M
Operating Income$-1.53M
Total Cash$54.72M
Total Debt$996K
Net Debt$-53.72M
Total Assets$148.7M
Price / Earnings (P/E)-7.8
Price / Sales (P/S)0.22
Analyst Forecast
1Y Price Target$7.00
Target High$19.00
Target Low$7.00
Upside+197.9%
Rating ConsensusHold
Analysts Covering10
Buy 20% Hold 60% Sell 20%
Price Target Summary
Company Info
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS7163821066

Price Chart

Track all markets on TradingView
PETS
PetMed Express, Inc. ↗  ·  NASDAQ Global Select
Healthcare • Medical - Pharmaceuticals
1.57 52WK RANGE 4.32

People Also View

WBA
WBA
Walgreens Boots Alliance, Inc.
$11.98
+0.50%
 HITI
HITI
High Tide Inc.
$2.34
+0.43%
 LFLY
LFLY
Leafly Holdings, Inc.
$37.00
+0.00%
 YI
YI
111, Inc.
$6.81
+0.29%
 RAD
RAD
Rite Aid Corporation
$0.65
-16.81%
 MEDS
MEDS
TRxADE HEALTH, Inc.
$7.59
+4.55%
 CJJD
CJJD
China Jo-Jo Drugstores, Inc.
$1.52
-5.59%
 SSY
SSY
SunLink Health Systems, Inc.
$1.12
+16.15%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message